IL18 and neoplasm: In mice with HIF1α-deficient NK cells, tumor control was enhanced either directly by increased IL-18 signaling that improved NK cell effector responses or indirectly through an absence of tumor-infiltrating NK cells, which altered the VEGF/VEGFR axis affecting productive angiogenesis.